Mainz Biomed N.V. (MYNZ) Income Statement (2025 - 2026)
Income Statement report data from Mar 31, 2025 to Mar 31, 2026 for Mainz Biomed N.V. (MYNZ).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Mar 31, 2025 | |
|---|---|---|
Operating Expenses | ||
Research And Development | 60K (-33.33%) | 90K |
Selling General And Administrative | 2.12M (+41.33%) | 1.50M |
Operating Expenses | 2.46M (-10.55%) | 2.75M |
Depreciation And Amortization | 60K (-62.50%) | 160K |
Operating Income | ||
Operating Income | -2.46M (-10.55%) | -2.75M |
Ebit | -2.46M (-10.55%) | -2.75M |
EBITDA | -2.41M (-6.59%) | -2.58M |
Other Income / Expenses | ||
Interest Expense | 20K (-33.33%) | 30K |
Other Non Operating Income | -20.00K (0.00%) | -20.00K |
Net Income | ||
Income Before Tax | -2.49M (-10.11%) | -2.77M |
Net Income From Continuing Operations | -5.08M (+1.60%) | -5.00M |
Net Income | -5.08M (+1.60%) | -5.00M |
Comprehensive Income Net Of Tax | -5.12M (+5.79%) | -4.84M |